Raymond James Maintains Outperform on Axogen, Raises Price Target to $53

Benzinga Newsdesk www.benzinga.com Positive 82.4%

Neg 0% Neu 0% Pos 82.4%

Raymond James analyst Jayson Bedford maintains Axogen (NASDAQ:AXGN) with a Outperform and raises the price target from $48 to $53.